Profile: Tania Jain, MBBS Johns Hopkins School of Medicine, Baltimore, MD, USA Introducing Dr. Tania Jain Dr. Tania Jain’s fascination with science began in her childhood as a way to explain the world around her. However, as she delved deeper into medicine, she gravitated towards a specialty filled with unanswered questions. “What drew me to… Read More »Tania Jain, MBBS Research Profile
Historically, MPNS are diagnosed in adults 60 years or older. In recent years, however, there has been recognition of essential thrombocythemia (ET), polycythemia vera (PF), and primary myelofibrosis (PMF) in adolescents and young adults, often referred to as AYAs. A recent article in British Journal of Haematology offers a comprehensive review of the literature about AYAs, authored… Read More »Growing knowledge of MPNs in adolescents and young adults
Need help with MPN related out of pocket expenses? The PAN Foundation is helping patients with Philadelphia chromosome negative myeloproliferative neoplasms (MPN) afford their out-of-pocket costs. If you’re a patient or caregiver looking for resources to help with your treatment-related costs, we encourage you to learn more about the PAN Foundation and its $3,250 annual… Read More »Need help with MPN related out-of-pocket expenses?
To stay up to date on everything MPNs, patients and their families and caregivers have access to a just updated resource that includes 75 pages of plain language questions, answers, and explanations written specifically for people affected by MPNs. The comprehensive document is based on current clinical practice guidelines created by national leaders in the… Read More »MPN patient guidelines updated by NCCN
Profile: Vikas Gupta, MD, FRCP, FRCPPath Princess Margaret Cancer Centre University Health Network, Toronto, Canada How can we best study transplant vs best available non-transplant therapies in myelofibrosis patients? According to Dr. Vikas Gupta, studies have shown that high-risk myelofibrosis (MF) patients appear to have better survival with hematopoietic stem cell transplants (HCT) than with… Read More »Vikas Gupta, MD, FRCP, FRCPPath
The fight against blood cancers has taken a significant step forward with new research into the GADD45g gene. Researchers have uncovered surprising insights into the role of GADD45g in myeloproliferative neoplasms (MPNs), providing scientists with a laundry list of related proteins to examine for potential therapeutic targeting. A notable study recently published in Nature Communications… Read More »The New MPN Protein: Insights from GADD45g Research
May is Skin Cancer Awareness Month. Research shows a link between skin cancers and MPNs. Diligent screening is crucial for those living with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Skin cancers, particularly non-melanomas, offer an example of how quickly and impactfully research can move to action that saves lives. A recently published… Read More »Skin Cancer Awareness Month: Non-melanoma skin cancer and MPNs
Through a strategic collaboration between MPN Research Foundation and Medscape, people living with myelofibrosis (MF) and their care partners can learn more about MF, then test their knowledge about this chronic blood cancer. In addition to providing basic facts about primary and secondary myelofibrosis, this interactive exercise includes current insight about how to manage your… Read More »Medscape Partners with MPNRF to help MF patients work with their care teams
This spring allergy season, if you suffer from the distraction and annoyance of itchy eyes or nose, imagine that intense itch across your entire body – every day of the year. That’s what many people living with polycythemia vera (PV) and other MPNs experience. Severe, recurrent MPN-related pruritus (the condition of itching) can have a… Read More »Severe Itching Remains an MPN Research Challenge
The transformation of MPNs to blast-phase (BP) is generally associated with poorer long-term survival. A recently published study in Blood Advances looked at outcomes of intensive and non-intensive blast reduction strategies in both the blast phase and accelerated phase of MPNs. Blasts are immature white blood cells found naturally in the bone marrow and circulating… Read More »Reducing Blasts in MPNs
